Cancer News and Research

Latest Cancer News and Research

Phase II study: Hepatitis C patients receiving ANA598 bid plus SOC attain undetectable levels of virus

Anadys Pharmaceuticals, Inc. announced today that 72% of hepatitis C patients receiving ANA598 400 mg twice daily (bid) plus standard of care achieved undetectable levels of virus at week eight in an ongoing Phase II study, compared to 38% of patients receiving placebo plus SOC.

19 Apr 2010

Stanford researchers discover tissue-specific target in pathogen

A tumor-causing maize fungus with the unsavory-sounding name "corn smut" wields different weapons from its genetic arsenal depending on which part of the plant it infects. The discovery by Stanford researchers marks the first time tissue-specific targeting has been found in a pathogen.

19 Apr 2010

Radiolabeled hedgehog can differentiate stem-like cancer cells, identify aggressive tumors

At the American Association for Cancer Research 101st Annual Meeting 2010, scientists and clinicians will present more than 6,300 abstracts dealing with innovative aspects of biology, technology and emerging therapies.

19 Apr 2010

Study reveals increased risk for cancer among Latino populations

New findings from epidemiology and observational studies show an increased risk for cancer among Latino populations, but unique demographic characteristics suggest the problem may be worse than currently known.

19 Apr 2010

New insights into yeast cells may help identify cancer cells and stem cells development: Study

Yeast cells decide whether to have sex with each other within two minutes of meeting, according to new research published today in Nature. One of the authors of the study, from Imperial College London, says the new insights into how yeast cells decide to mate could be helpful for researchers looking at how cancer cells and stem cells develop.

19 Apr 2010

Stallergenes' US phase III clinical trial of Oralair achieves primary endpoint

Stallergenes S.A. today announced the first results of a phase III clinical trial (VO61.08) conducted in the USA on its sublingual grass pollen immunotherapy tablet, Oralair(R).

19 Apr 2010

New p53 knockout rat model improves timelines for carcinogenicity screening

Sigma Life Science, the innovative biological products and services brand of Sigma-Aldrich, today introduced the world's first p53 'knockout' rat model, an important development that is expected to, due to the rat's closer physiological and metabolic similarity to humans, significantly improve timelines for carcinogenicity screening and reduce time to market for therapeutics.

19 Apr 2010

Amgen announces results from pivotal Phase 3 "408" trial of Vectibix

Amgen today announced detailed results from a new biomarker analysis of the pivotal Phase 3 "408" trial of Vectibix® (panitumumab) plus best supportive care compared to BSC alone. The analysis used massively parallel, next-generation sequencing technology to investigate whether mutations in nine genes known to be mutated in colorectal cancer, including the previously unanalyzed exon 3 mutation of the KRAS gene, are predictive of response to Vectibix in metastatic colorectal cancer.

19 Apr 2010

Results of BATTLE Trial presented at AACR 2010

Lung cancer is the number one cause of cancer death in men and women, but huge randomized trials of thousands of patients have either failed completely or shown negligible survival differences.

19 Apr 2010

EORTC 30904 study: Conservative surgery not inferior to radical renal surgery

The latest results from the European Organisation for Research and Treatment of Cancer (EORTC) 30904 study were presented in a plenary session today at the Anniversary European Association of Urology Congress in Barcelona, which showed that conservative surgery is not inferior to radical renal surgery or nephrectomy.

19 Apr 2010

Cell Therapeutics receives feedback regarding proposed filing of MAA for pixantrone

Cell Therapeutics, Inc. today announced that it met with and received feedback from the rapporteurs and the European Medicines Agency's medical reviewers regarding a proposed filing of a Marketing Authorization Application for pixantrone in the European Union to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.

19 Apr 2010

HEALTHPOINT provides donation to support 100 free AAWC patient memberships

HEALTHPOINT today announced it will provide a donation to the Association for the Advancement of Wound Care Patient Advocacy Campaign to support 100 free AAWC patient memberships. The AAWC initiative is to be formally launched today during the Opening Ceremony of the Spring 2010 Symposium on Advanced Wound Care, on April 17, 2010, from 2:15-3:00 PM at the Gaylord Palms Hotel and Convention Center in Orlando, FL.

19 Apr 2010

New in vitro study results of Hydrofiber dressing to be presented at SAWC/WHS 2010

ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced new in vitro study results in which a Hydrofiber dressing containing ionic silver was observed to conform more closely to a porcine tissue surface in a shallow wound model than did certain silver-containing foam dressings following hydration.

19 Apr 2010

Clues to molecular markers on breast tumors that may predict spread of lymph node cancer

Predicting breast cancer spread from a sentinel lymph node removed during surgery is a hit or miss affair, say researchers: there are still many false negatives, which means the node, when analyzed under a microscope, appears clean of cancer cells, but metastasis can still occur in the patient. The sentinel node is the first lymph node in the axilla that cancer spreads to.

19 Apr 2010

Study: Tobacco company's nicotine pellet can lead to accidental nicotine poisoning in children

A tobacco company's new, dissolvable nicotine pellet--which is being sold as a tobacco product, but which in some cases resembles popular candies--could lead to accidental nicotine poisoning in children, according to a new study from the Harvard School of Public Health, the Northern Ohio Poison Control Center, the Centers for Disease Control and Prevention and the Food and Drug Administration.

19 Apr 2010

Study shows long-term effect of vitamins and calcium supplements in breast cancer reduction

Vitamins and calcium supplements appear to reduce the risk of breast cancer, according to findings presented at the American Association for Cancer Research 101st Annual Meeting 2010.

19 Apr 2010

Leona Fields honoured for exceptional leadership as New Run Director for York Region

Leona Fields is a breast cancer survivor, accomplished fundraiser, active volunteer, gifted spokesperson, and two-time winner of a Canadian Breast Cancer Foundation - Ontario Region Volunteer Award. This year, she was honoured for her exceptional leadership as a New Run Director for York Region, Leona's home turf, where the Foundation launched a new Run site for the 2009 Canadian Breast Cancer Foundation CIBC Run for the Cure.

19 Apr 2010

Debate continues over prostate cancer screening in Europe

The European Association of Urology reiterated that it does not recommend a mass screening policy in Europe for men who are concerned over prostate cancer, a stance which reflects the position it issued last year regarding prostate cancer screening. "We don't believe that the time has come for mass screening," said EAU Secretary General.

19 Apr 2010

Role of lactate in breast cancer development to be showcased at AACR 2010

Does lactate play a role in the metabolic fate of cancer cells? Researchers from The Cancer Institute of New Jersey are in Washington, D.C., this week for the 101st Annual Meeting of the American Association for Cancer Research to share their findings on what role this common energy byproduct in the body plays in the development of breast cancer cells and surrounding connective tissue.

19 Apr 2010

Study evaluates therapeutic effects of FXR and TGR5 agonist in PSC

Results of a study presented today at the International Liver Congress 2010 demonstrate that a dual FXR and TGR5 agonist decreases liver damage and modulates hepatic inflammation and fibrosis in a mouse model of primary sclerosing chlolangitis. In contrast, selective FXR or TGR5 agonists have no beneficial effect.

19 Apr 2010

Cancer News and Research

Latest Cancer News and Research

Phase II study: Hepatitis C patients receiving ANA598 bid plus SOC attain undetectable levels of virus

Stanford researchers discover tissue-specific target in pathogen

Radiolabeled hedgehog can differentiate stem-like cancer cells, identify aggressive tumors

Study reveals increased risk for cancer among Latino populations

New insights into yeast cells may help identify cancer cells and stem cells development: Study

Stallergenes' US phase III clinical trial of Oralair achieves primary endpoint

New p53 knockout rat model improves timelines for carcinogenicity screening

Amgen announces results from pivotal Phase 3 "408" trial of Vectibix

Results of BATTLE Trial presented at AACR 2010

EORTC 30904 study: Conservative surgery not inferior to radical renal surgery

Cell Therapeutics receives feedback regarding proposed filing of MAA for pixantrone

HEALTHPOINT provides donation to support 100 free AAWC patient memberships

New in vitro study results of Hydrofiber dressing to be presented at SAWC/WHS 2010

Clues to molecular markers on breast tumors that may predict spread of lymph node cancer

Study: Tobacco company's nicotine pellet can lead to accidental nicotine poisoning in children

Study shows long-term effect of vitamins and calcium supplements in breast cancer reduction

Leona Fields honoured for exceptional leadership as New Run Director for York Region

Debate continues over prostate cancer screening in Europe

Role of lactate in breast cancer development to be showcased at AACR 2010

Study evaluates therapeutic effects of FXR and TGR5 agonist in PSC

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in